Support from the National Science Foundation’s Small Business Innovation Research (SBIR) program is helping a Morgridge research team bring an important cancer immunotherapy technology to market.
Author: Brian Mattmiller
Donor generosity helps prime discovery at Morgridge
Two Morgridge investigators in 2025 have received donor-funded named professorships, which provide invaluable support for ongoing research and new opportunities.
For effective science communication, ‘just the facts’ isn’t good enough
Scientists who show humility and recognize that science “doesn’t have all the answers” will be more effective communicators with society, argues Morgridge PI Dietram Scheufele.
Study shows environmental conditions alter dependence on a key metabolic enzyme
At the intersection of genetic rules and environmental conditions, scientists at Morgridge are gathering new insights about how diseases function in the human body.
New cancer imaging startup harnesses Wisconsin expertise
Morgridge scientists are working with a Madison biomedical company to improve the success rates of cancer immunotherapy treatments, which harness patients’ own immune response to fight cancer.
